| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 473,668 | 440,508 | 431,816 | 455,928 | | Cost of Revenue | 320,675 | 288,826 | 289,721 | 308,950 | | | Gross Profit | 152,993 | 151,682 | 142,095 | 146,978 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 67,001 | 71,008 | 72,688 | 66,360 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 33,054 | 31,435 | 30,101 | 31,281 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 52,938 | 49,239 | 39,306 | 49,337 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 608 | (399) | 1,156 | 1,918 | | Earnings Before Interest And Taxes | 53,546 | 48,840 | 40,462 | 51,166 | | Interest Expense | 3,965 | 5,157 | 3,447 | 4,483 | | Income Before Tax | 49,581 | 43,683 | 37,015 | 46,683 | | Income Tax Expense | 16,114 | 15,211 | 10,421 | 15,013 | | Minority Interest | 90 | (71) | 71 | 18 | | | | Net Income From Continuing Ops | 33,557 | 28,401 | 26,665 | 31,670 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,557 | 28,401 | 26,665 | 31,670 | | Preferred Stock And Other Adjustments | (59) | 59 |
-
|
-
| | | Net Income Applicable To Common Shares | $33,498 | $28,460 | $26,665 | $31,670 |
|
1.52% Nasdaq 0.00%
Income Statement
